These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 902700)
1. The interaction of erythropoietin with fetal liver cells. II. Inhibition of the erythropoietin effect by interferon. Smith KA; Fredrickson TN; Mobraaten LE; DeMaeyer E Exp Hematol; 1977 Sep; 5(5):333-40. PubMed ID: 902700 [TBL] [Abstract][Full Text] [Related]
2. The interaction of erythropoietin with fetal liver cells. I. Measurement of proliferation by tritiated thymidine incorporation. Fredrickson TN; Smith KA; Cornell CJ; Jasmin C; McIntyre OR Exp Hematol; 1977; 5(4):254-65. PubMed ID: 891665 [TBL] [Abstract][Full Text] [Related]
3. The erythrotropins, new factors which stimulate thymidine incorporation and globin chain synthesis in liver erythroid cells. Congote LF Prog Clin Biol Res; 1984; 165():29-45. PubMed ID: 6504913 [TBL] [Abstract][Full Text] [Related]
4. Effect of the interaction between transforming growth factor beta and erythropoietin on the proliferation of normal erythroid progenitors and leukemic UT-7 cells: action of transforming growth factor beta on the erythropoietin receptor. Leveque E; Nagel MD; Haye B Hematol Oncol; 1996 Sep; 14(3):137-46. PubMed ID: 9119358 [TBL] [Abstract][Full Text] [Related]
5. Erythropoiesis in the aged mouse: II. Response to stimulation in vitro. Udupa KB; Lipschitz DA J Lab Clin Med; 1984 Apr; 103(4):581-8. PubMed ID: 6699473 [TBL] [Abstract][Full Text] [Related]
6. Effects of insulin-like growth factor I, platelet-derived growth factor, fibroblast growth factor, and transforming growth factor-beta on thymidine incorporation into fetal liver cells. Congote LF Exp Hematol; 1987 Oct; 15(9):936-41. PubMed ID: 3477468 [TBL] [Abstract][Full Text] [Related]
7. Polyamines as an inhibitor on erythropoiesis of hemodialysis patients by in vitro bioassay using the fetal mouse liver assay. Yoshida K; Yoneda T; Kimura S; Fujimoto K; Okajima E; Hirao Y Ther Apher Dial; 2006 Jun; 10(3):267-72. PubMed ID: 16817792 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of the primary in vitro antibody response by interferon preparations. Johnson HM; Smith BG; Baron S J Immunol; 1975 Jan; 114(1 Pt 2):403-9. PubMed ID: 1090660 [TBL] [Abstract][Full Text] [Related]
9. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver. Mayani H; Little MT; Dragowska W; Thornbury G; Lansdorp PM Exp Hematol; 1995 May; 23(5):422-7. PubMed ID: 7536684 [TBL] [Abstract][Full Text] [Related]
10. Shape-dependent regulation of proliferation in normal and malignant human cells and its alteration by interferon. Kulesh DA; Greene JJ Cancer Res; 1986 Jun; 46(6):2793-7. PubMed ID: 2421883 [TBL] [Abstract][Full Text] [Related]
11. The cell-growth inhibitory effect of interferon. Studies of a resistant cell-subline. Borecký L; Fuchsberger N; Hajnická-Gondová V; Clampor F; Altaner C Neoplasma; 1977; 24():125-37. PubMed ID: 194167 [TBL] [Abstract][Full Text] [Related]
12. Oxymetholone and erythropoiesis: failure to detect an effect in fetal mouse liver cell cultures. Dunn CD; Napier JA; Ford TW; Price VA Exp Hematol; 1977 Nov; 5(6):546-50. PubMed ID: 590407 [TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma exerts its negative regulatory effect primarily on the earliest stages of murine erythroid progenitor cell development. Wang CQ; Udupa KB; Lipschitz DA J Cell Physiol; 1995 Jan; 162(1):134-8. PubMed ID: 7814445 [TBL] [Abstract][Full Text] [Related]
14. Suppression of normal human erythropoiesis by human recombinant DNA-produced alpha-2-interferon in vitro. Mamus SW; Oken MM; Zanjani ED Exp Hematol; 1986 Dec; 14(11):1015-22. PubMed ID: 3780887 [TBL] [Abstract][Full Text] [Related]
15. Action of antithymocyte globulin on normal human erythroid progenitor cell proliferation in vitro: erythropoietic growth-enhancing factors are released from marrow accessory cells. Mangan KF; D'Alessandro L; Mullaney MT J Lab Clin Med; 1986 Apr; 107(4):353-64. PubMed ID: 2420910 [TBL] [Abstract][Full Text] [Related]
16. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity. Murate T; Yamashita K; Ohashi H; Kagami Y; Tsushita K; Kinoshita T; Hotta T; Saito H; Yoshida S; Mori KJ Exp Hematol; 1993 Jan; 21(1):169-76. PubMed ID: 8417953 [TBL] [Abstract][Full Text] [Related]
17. On the mechanisms of the antitumor effects of interferon. Gresser I Tex Rep Biol Med; 1977; 35():394-8. PubMed ID: 358464 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of interferon on multiplication of Friend leukemia cells in vivo. Rossi GB; Marchegiani M; Matarese GP; Gresser I J Natl Cancer Inst; 1975 Apr; 54(4):993-6. PubMed ID: 1127730 [TBL] [Abstract][Full Text] [Related]
19. Studies of interferon as a regulator of hematopoietic cell proliferation. Raefsky EL; Platanias LC; Zoumbos NC; Young NS J Immunol; 1985 Oct; 135(4):2507-12. PubMed ID: 2411798 [TBL] [Abstract][Full Text] [Related]
20. Employment of a [3H]thymidine-incorporation assay to distinguish the effects of different Friend erythroleukemia-inducing retroviruses on erythroid cell proliferation. Ruscetti SK J Natl Cancer Inst; 1986 Jul; 77(1):241-5. PubMed ID: 3459916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]